[go: up one dir, main page]

CA2343049A1 - Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose - Google Patents

Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose Download PDF

Info

Publication number
CA2343049A1
CA2343049A1 CA002343049A CA2343049A CA2343049A1 CA 2343049 A1 CA2343049 A1 CA 2343049A1 CA 002343049 A CA002343049 A CA 002343049A CA 2343049 A CA2343049 A CA 2343049A CA 2343049 A1 CA2343049 A1 CA 2343049A1
Authority
CA
Canada
Prior art keywords
vitamin
receptor
gene
genotype
estrogen receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002343049A
Other languages
English (en)
Inventor
Francois Rousseau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Laval
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2343049A1 publication Critical patent/CA2343049A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002343049A 1998-09-15 1999-09-15 Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose Abandoned CA2343049A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10044698P 1998-09-15 1998-09-15
US60/100,446 1998-09-15
PCT/CA1999/000854 WO2000015836A2 (fr) 1998-09-15 1999-09-15 Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose

Publications (1)

Publication Number Publication Date
CA2343049A1 true CA2343049A1 (fr) 2000-03-23

Family

ID=22279811

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002343049A Abandoned CA2343049A1 (fr) 1998-09-15 1999-09-15 Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose

Country Status (4)

Country Link
EP (1) EP1114181A2 (fr)
AU (1) AU5723399A (fr)
CA (1) CA2343049A1 (fr)
WO (1) WO2000015836A2 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006522A2 (fr) * 2000-07-15 2002-01-24 Signalgene Inc. Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible
CA2657478A1 (fr) * 2006-07-12 2008-01-24 Progenika Biopharma S.A. Methode diagnostique
JPWO2008016155A1 (ja) 2006-07-31 2009-12-24 国立大学法人 東京大学 ビタミンｄ受容体リガンドのスクリーニング方法
CN111394452A (zh) * 2020-04-23 2020-07-10 长沙金域医学检验实验室有限公司 基于探针法实现维D受体ApaI位点准确分型的引物组合物、试剂、检测方法和系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM701594A0 (en) * 1994-07-25 1994-08-18 Garvan Institute Of Medical Research Diagnostic method
AUPN058895A0 (en) * 1995-01-16 1995-02-09 Garvan Institute Of Medical Research Diagnostic method
WO1997027321A1 (fr) * 1996-01-25 1997-07-31 Universite Laval Marqueur du gene recepteur des oestrogenes pour la determination des predispositions a l'osteoporose
WO1997032998A2 (fr) * 1996-03-08 1997-09-12 Isis Innovation Limited Materiels et procedes relatifs a l'identification d'un polymorphisme associe a une sensibilite a des pathologies
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis

Also Published As

Publication number Publication date
WO2000015836A3 (fr) 2000-06-08
AU5723399A (en) 2000-04-03
WO2000015836A2 (fr) 2000-03-23
EP1114181A2 (fr) 2001-07-11

Similar Documents

Publication Publication Date Title
JP4048053B2 (ja) 特発性全身てんかんについてのローカス、当該ローカスのミューテーション、及びてんかんの評価、診断、予後、または治療のための当該ローカスの使用方法
US5879884A (en) Diagnosis of depression by linkage of a polymorphic marker to a segment of chromosome 19P13 bordered by D19S247 and D19S394
EP1210426A2 (fr) Polymorphismes dans un gene klotho
AU718326B2 (en) Determination of collagen genotype
JP2002330758A (ja) 化学化合物
US20110038944A1 (en) Compositions and methods for diagnosis and treatment of hepatobiliary disease and associated disorders
CA2343049A1 (fr) Combinaison de marqueurs au niveau des genes recepteurs des oestrogenes et de la vitamine d, ou equivalents de ces derniers, pour le pronostic d'une reponse au traitement de l'osteoporose
AU1940001A (en) Nucleic acids containing single nucleotide polymorphisms and methods of use thereof
EP1282726A2 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples, et procedes d'utilisation correspondants
US20060040263A1 (en) Marker at the androgen receptor gene for determining breast cancer susceptibility
MXPA06012744A (es) Marcadores de haplotipo y metodos para utilizarlos en la determinacion de la respuesta al tratamiento.
JP2005278479A (ja) 関節リウマチ検査用マーカー遺伝子
US20030008301A1 (en) Association between schizophrenia and a two-marker haplotype near PILB gene
WO2001073116A2 (fr) Methode permettant de determiner la probabilite d'etre atteint d'osteoporose et/ou une faible densite osseuse, et reactifs destines a cette methode
WO2001081633A1 (fr) Association de polymorphismes de la proteine kinase c zeta aux diabetes
CA2343572C (fr) Marqueur au niveau du gene recepteur de la vitamine d, utilise pour la determination de la sensibilite au cancer du sein
WO2002006522A2 (fr) Marqueur du gene du recepteur de l'oestrogene permettant de determiner la predisposition a une densite osseuse faible
US20060211774A1 (en) Method of diagnosins a genetic susceptibility for bone damage
WO1996017081A1 (fr) Evaluation en vue d'un traitement par des agents neuroleptiques
WO2001078575A2 (fr) $i(ext2) utilise comme marqueur predictif de l'osteoporose
JP2002521061A (ja) ヒトのニューロキニン２受容体遺伝子における遺伝多型、並びに疾患の診断および処置におけるそれらの使用
WO2001038586A2 (fr) Acides nucleiques contenant des polymorphismes de nucleotides simples et methodes d'utilisation correspondantes
JP2001078773A (ja) 骨粗鬆症薬剤感受性予測方法
JP2007503806A (ja) ヒト肥満感受性遺伝子およびその使用
MXPA98007040A (en) Determination of the collage genotype

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead